New stomach-shrinking tools battle bulge without surgery

NCT ID NCT07090005

Recruiting now Disease control Sponsor: Nitinotes Surgical Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two minimally invasive procedures, EndoZip and Apollo ESG, to help people with obesity lose weight. Participants are adults aged 21-65 with a BMI of 30-50 who have not succeeded with non-surgical methods. Both procedures reshape the stomach using an endoscope, followed by diet and behavior changes, and the study measures weight loss after 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY OVERWEIGHT

Contacts and locations

Locations

Cedars Sinai Medical Center
ACTIVE_NOT_RECRUITING

Los Angeles, California, 90048, United States
Lenox Hill Hospital | Northwell Health
RECRUITING

New York, New York, 10075, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.